Ellen Kurek

News
Model Predicts Presence of Occult Nodal Metastasis Better Than Current Standard in Early-Stage Oral Cavity Squamous Cell Carcinoma
05/18/2022
Machine learning models that were developed from multi-institutional clinicopathologic data may reduce the number of pathologically node-negative neck dissections and accurately identify patients with early OCSCC who are at highest risk for...
Machine learning models that were developed from multi-institutional clinicopathologic data may reduce the number of pathologically node-negative neck dissections and accurately identify patients with early OCSCC who are at highest risk for...
Machine learning models that...
05/18/2022
Journal of Clinical Pathways
News
Consortium Explores Racial Differences in Treatment and Toxicity in Patients With Non-Small Cell Lung Cancer Receiving Definitive Thoracic Radiotherapy
04/20/2022
Black patients reported significantly greater general pain both before the initiation of radiation therapy and at the end of radiation therapy, according to an analysis of racial differences in thoracic radiation treatment and related...
Black patients reported significantly greater general pain both before the initiation of radiation therapy and at the end of radiation therapy, according to an analysis of racial differences in thoracic radiation treatment and related...
Black patients reported...
04/20/2022
Journal of Clinical Pathways
News
Increased Costs Associated With Excessive Surveillance and Treatment For Non–Muscle-Invasive Bladder Cancer
04/14/2022
The annual median one-year cost of care for low-grade, non–muscle-invasive bladder cancer increased by 60%, or nearly $20,000, from 2004 to 2013, according to a population-based cohort study.
The annual median one-year cost of care for low-grade, non–muscle-invasive bladder cancer increased by 60%, or nearly $20,000, from 2004 to 2013, according to a population-based cohort study.
The annual median one-year cost...
04/14/2022
Journal of Clinical Pathways
Conference Coverage
Exploring Real-World Data on the Efficacy and Safety of Oncology Drugs
06/14/2022
A study presented at the ASCO Annual Meeting aimed to establish a data collection framework of EMR-based real-world data to evaluate the effectiveness and safety of cancer drugs.
A study presented at the ASCO Annual Meeting aimed to establish a data collection framework of EMR-based real-world data to evaluate the effectiveness and safety of cancer drugs.
A study presented at the ASCO...
06/14/2022
Journal of Clinical Pathways
News
Cost and Utilization of Daratumumab in Patients With Multiple Myeloma
05/02/2022
In patients with multiple myeloma, daratumumab is utilized more frequently than the FDA-recommended dosing, which may lead to higher treatment costs.
In patients with multiple myeloma, daratumumab is utilized more frequently than the FDA-recommended dosing, which may lead to higher treatment costs.
In patients with multiple...
05/02/2022
Journal of Clinical Pathways
News
Bevacizumab-bvzr Biosimilar Used Most Frequently for Metastatic Colorectal Cancer in US Oncology Practice, According to Retrospective Cohort Study
06/09/2022
This study finds that US oncologists have adopted switching between the bevacizumab reference product and bevacizumab biosimilars as well as using bevacizumab-bvzr in chemotherapy combination regimens.
This study finds that US oncologists have adopted switching between the bevacizumab reference product and bevacizumab biosimilars as well as using bevacizumab-bvzr in chemotherapy combination regimens.
This study finds that US...
06/09/2022
Journal of Clinical Pathways
News
Retrospective Study Identifies Surgical Treatment Patterns, Health Care Resource Utilization, and Economic Burden Associated With Tenosynovial Giant Cell Tumors
05/25/2022
While surgical resection alone might be an inadequate approach to controlling TGCT, new treatment options may complement surgery and alleviate the clinical and economic burden among patients with TGCT who received prior surgery.
While surgical resection alone might be an inadequate approach to controlling TGCT, new treatment options may complement surgery and alleviate the clinical and economic burden among patients with TGCT who received prior surgery.
While surgical resection alone...
05/25/2022
Journal of Clinical Pathways
Conference Coverage
Gold Nanoparticles’ Role in Photodynamic Therapy for Cancer Treatment
07/22/2022
Researchers highlight the importance of health care providers’ awareness of advancements and utility of photodynamic therapy as a way to provide a less invasive, more effective way to treat patients with cancer.
Researchers highlight the importance of health care providers’ awareness of advancements and utility of photodynamic therapy as a way to provide a less invasive, more effective way to treat patients with cancer.
Researchers highlight the...
07/22/2022
Journal of Clinical Pathways
News
Implementing an EHR-Integrated Symptom and Needs Screening and Referral System for Spanish-Speaking Oncology Patients
04/14/2022
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate encouraging feasibility and initial acceptability of implementing an EHR-integrated symptom and needs screening and referral system among diverse oncology patients.
Study findings demonstrate...
04/14/2022
Journal of Clinical Pathways
Conference Coverage
Examining the Prevalence of Prior Authorizations for Use of PARP Inhibitors in Ovarian Cancer
06/14/2022
Researchers at the 2022 ASCO Annual Meeting examined the prevalence of prior authorization for PARP inhibitors among patients with ovarian cancer overall, by frontline or recurrent maintenance, and by genetic status.
Researchers at the 2022 ASCO Annual Meeting examined the prevalence of prior authorization for PARP inhibitors among patients with ovarian cancer overall, by frontline or recurrent maintenance, and by genetic status.
Researchers at the 2022 ASCO...
06/14/2022
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use